← Browse by Condition
Medical Condition

oxidative stress

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for oxidative stress sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — oxidative stress Clinical Trials

How many clinical trials are currently recruiting for oxidative stress?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for oxidative stress, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for oxidative stress?
oxidative stress research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a oxidative stress clinical trial?
Eligibility criteria for oxidative stress trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
University of Calgary 1 trial
Recep Tayyip Erdogan University Training and Research Hospital 1 trial
Javier Marhuenda 1 trial
Hubei Cancer Hospital 1 trial
University of La Laguna 1 trial

Recruiting Clinical Trials

NCT03255408 Phase 1, Phase 2
Recruiting
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Enrollment
12 pts
Location
Canada
Sponsor
University of Calgary
View Trial →
NCT07666126
Recruiting
Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss
Enrollment
80 pts
Location
Turkey (Türkiye)
Sponsor
Recep Tayyip Erdogan Universit...
View Trial →
NCT07433998
Recruiting
Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function
Enrollment
50 pts
Location
Spain
Sponsor
Javier Marhuenda
View Trial →
NCT07263347
Recruiting
DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
Enrollment
30 pts
Location
China
Sponsor
Hubei Cancer Hospital
View Trial →
NCT07760662
Recruiting
Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis
Enrollment
200 pts
Location
Spain
Sponsor
University of La Laguna
View Trial →
NCT06438445
Recruiting
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Enrollment
30 pts
Location
Brazil
Sponsor
Universidade Federal Fluminens...
View Trial →

Related Conditions

obstructive sleep apnea of adult (1) hypoxia brain (1) sleep apnea (1) sleep disorder (1) stroke (1) blood pressure (1) endothelial dysfunction (1) periodontal diseases (1) hyperuricemia (1) inflammation biomarkers (1) cardiometabolic risk factors (1) breast neoplasms (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology